Adimmune (TPE:4142) Marketable Securities : NT$128 Mil (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Adimmune Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Adimmune's Marketable Securities for the quarter that ended in Mar. 2025 was NT$128 Mil.

Adimmune's annual Marketable Securities declined from Dec. 2022 (NT$116 Mil) to Dec. 2023 (NT$28 Mil) but then increased from Dec. 2023 (NT$28 Mil) to Dec. 2024 (NT$128 Mil).

Adimmune Marketable Securities Historical Data

The historical data trend for Adimmune's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adimmune Marketable Securities Chart

Adimmune Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

349.56

239.00

115.51

27.51

127.51

Adimmune Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Marketable Securities	Get a 7-Day Free Trial															27.51	63.51	63.51	127.51	127.51

Adimmune Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Adimmune (TPE:4142) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Adimmune Marketable Securities Related Terms

Thank you for viewing the detailed overview of Adimmune's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Adimmune Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adimmune Corp (TPE:4142) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tanxing Road, No. 3, Sector 1, Tanzi District, Taichung, TWN, 427003

Website

https://www.adimmune.com.tw

Adimmune Corp is a Taiwan-based company. It is engaged in the development, manufacture, and distribution of vaccines and other biological products. Its pipeline consists of products like AdimFlu-S (QIS) which is a vaccine intended for use in the prevention of influenza, and TetraFlu among others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the USA, China, and other regions.

Adimmune Headlines

No Headlines